“borderline significant”

There is also a borderline significant inter- action between birthweight and age at menarche (P = 0.05), with a stronger effect of birthweight in girls with earlier puberty.

Suspension exercise therapy (SET, 3 studies) demonstrated borderline significant effects (SMD = −3.07, 95% CI: −6.18 to 0.04, Z = 1.94, P = 0.05) with extraordinary heterogeneity ( I 2 = 99%), where Guo 2018 (SMD = −5.70) and Niu 2019 (SMD = −2.63) contributed extreme effect sizes that substantially influenced the pooled estimate.

In females, we also found a borderline significant association of higher plasma IGF1 levels with cardiovascular mortality (0.43, 0.18–1.00; p = 0.05; see Supplemental Table S2 , Model 1), but neither a significant association with cancer-related mortality (1.50, 0.45–4.93; p = 0.51; see Supplemental Table S3 , Model 1), nor with mortality from miscellaneous causes (0.43, 0.10–1.78; p = 0.24; see Supplemental Table S4 , Model 1).

Being consistently inactive was associated with higher odds of having overweight/obesity according to all outcomes (borderline significant for WHtR ≥ 0.6 (p = 0.05)) compared to being consistently active.

The Kaplan–Meier analysis showed a meaningfully different and borderline significant risk of CVD/mortality for patients with proteinuria >1 g/d at baseline ( P = 0.05; Figure 2 A).

This trend was reflected in our meta-analysis, which showed a borderline significant reduction in the odds of requiring mechanical ventilation in vitamin D-sufficient patients (p=0.05), further reinforcing the potential respiratory benefits of adequate vitamin D levels in this population.

When grouped by the number of medications patients were on at the 20-year mark, there was a borderline significant difference between the groups on 0-1 (n=61), 2-4 (n=46) and ≥5 (n=39) different medications (10-year OS 93%, 93% and 76% respectively, p=0.05).

RT+HMB produced modest and borderline significant improvements in handgrip strength (SMD 0.24; 95% CI 0.00–0.48; p = 0.05) and moderate benefits in Short Physical Performance Battery (SPPB) scores (SMD 0.54; 95% CI 0.12–0.95; p = 0.01).

Regarding vascular function markers, FMD (borderline significant p = 0.050), RI, AI, and SI were independently associated with a HR below 53 bpm.

For Pb, a borderline significant difference was detected ( p = 0.050), with tub gurnard showing slightly higher mean values; however, this finding is limited by the high proportion of missing Pb data (68.1%).

In terms of disease severity based on symptom score, there was a borderline significant correlation between tryptase level and symptom score ( r = 0.30, p = 0.05).

Post hoc analysis was thus undertaken in those with limiting angina (n = 1507; 13.8%) 47 which reported ivabradine to be associated with a borderline significant 24% reduction in the primary endpoint (hazard ratio, 0.76 [95% CI, 0.58–1.00]; P = 0.05) and a 42% reduction in hospitalization for MI (hazard ratio, 0.58 [95% CI, 0.37–0.92]).

Examining the RG and FG separately, the RG showed a significant 3.0-fold CK increase until week 3 ( p = 0.010), whereas the FG demonstrated only borderline significant changes by the factor 1.5 during the first week ( p = 0.05), peaking at 72 h after WB-EMS ( p = 0.048; r = 0.64).

The heterogeneity test (I 2 = 61%) was substantially high with a borderline significant value ( p = 0.05).

For instance, the negative and borderline significant path from COMP to PU (β = -0.14, p = 0.050) challenges conventional TAM/TOE expectations.

The association of plasma docosahexaenoic acid (DHA) levels with the risk of POAG was borderline significant (hazard ratio, 0.42; 95% confidence interval, 0.17–1.01; P = 0.05).

Our next analysis suggested that metronidazole treatment in CDI is significantly associated with a lower recurrence rate ( p = 0.001), while it also showed a trend toward improved outcomes and reduced mortality, although these associations were borderline significant ( p = 0.050).

A borderline significant association was noted for Cit-Fibα36–50 (OR = 5.33; p = 0.05; 95% CI: 1.08–26.18).

The difference in mean triglyceride level in the placebo group was not significant after the intervention, although there was a borderline significant difference in the intervention group (p=0.05); nevertheless, the changes in mean triglyceride level between the two groups did not indicate a significant difference.

For joint effects of metals, we found that co-exposure of Pb and Cd had a borderline significant association (p = 0.05) with low BMD, in current smokers, after adjustment for age, sex, region, income, and physical activity.

22 Two-way ANOVA showed a borderline significant effect of genotype on winning (F = 5.48, df = 2, 136, P = .05) but no significant effect of sex or sex by genotype interaction.

There was a borderline significant result between age and the outcome variable (p = 0.05).

Lastly, thrombocytopenia risk was non-significant for cabazitaxel versus other taxanes (RR = 1.47, 95% CI 0.76–2.83; I 2 = 0%) but borderline significant for C25 versus C20 (RR = 1.70, 95% CI 1.00–2.89; p = 0.05) (Fig. 9 ).

We observed a borderline significant increased risk for kidney disease (OR: 1.24, 95% CI: 1.00, 1.49, P = 0.05).

The OR at NPAR ≥ 0.92 remains at the borderline significant level ( P = 0.050), but the overall analysis does not support the existence of a threshold effect.